908 Newsroom

Latest News

12.23.20

908 Devices Announces Closing of Initial Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares

908 Devices Inc., a pioneer of purpose-built handheld and desktop mass spec devices for chemical and biomolecular analysis, today announced the closing of its upsized initial public offering of shares of its common stock, with 7,475,000 shares offered and sold...

Read More

908 Devices Announces Pricing of Initial Public Offering

12.18.20

908 Devices Names Kevin Hrusovsky, 30-year Biotechnology Veteran and Founder of Powering Precision Health, as Chairman of its Board of Directors

10.31.20

908 Devices Announces New Additions to Its Executive Team

10.15.20

SCIEX and 908 Devices Launch Solutions for the Characterization of Biotherapeutics

08.04.20

MX908 Selected for Central European CBRN-E Training Center’s First Response Training Program

06.10.20

Southern Scientific and 908 Devices Enter UK Distribution Partnership for MX908

05.27.20

Cell Culture Dish Presents Cool Tools – The Rebel Analyzer Enables Real-Time Comprehensive Media Analysis in a Benchtop Package

04.27.20

Teaming Up For Solutions

04.14.20

908 Devices and Transcenta Expand Joint Innovation Partnership

04.01.20

Our response to COVID-19

03.16.20

908 Devices’ Rebel named one of 2019’s top transformational laboratory technologies

03.11.20